Transenterix Inc (NYSEAMERICAN:TRXC) CFO Joseph P. Slattery sold 529,609 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $2.80, for a total value of $1,482,905.20. Following the completion of the sale, the chief financial officer now directly owns 440,974 shares of the company’s stock, valued at $1,234,727.20. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Transenterix Inc (NYSEAMERICAN:TRXC) traded up $0.07 on Thursday, reaching $2.64. The company’s stock had a trading volume of 4,711,681 shares, compared to its average volume of 3,229,587. Transenterix Inc has a one year low of $0.45 and a one year high of $5.00.

WARNING: This story was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at

TRXC has been the topic of several recent analyst reports. Zacks Investment Research downgraded Transenterix from a “buy” rating to a “sell” rating in a report on Tuesday, August 8th. Ladenburg Thalmann Financial Services set a $5.00 price target on Transenterix and gave the stock a “buy” rating in a report on Friday, October 20th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $4.00 price target (up from $3.75) on shares of Transenterix in a report on Monday, October 30th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $2.61.

An institutional investor recently raised its position in Transenterix stock. Ladenburg Thalmann Financial Services Inc. boosted its position in shares of Transenterix Inc (NYSEAMERICAN:TRXC) by 87.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 79,150 shares of the medical instruments supplier’s stock after purchasing an additional 37,000 shares during the quarter. Ladenburg Thalmann Financial Services Inc. owned about 0.05% of Transenterix worth $113,000 as of its most recent filing with the Securities & Exchange Commission.

Transenterix Company Profile

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Receive News & Stock Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related stocks with our FREE daily email newsletter.